Cabot Corporation $CBT Stock Holdings Boosted by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its position in Cabot Corporation (NYSE:CBT) by 4.8% during the first quarter, Holdings Channel reports. The fund owned 1,742,782 shares of the specialty chemicals company’s stock after purchasing an additional 79,499 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Cabot were worth $131,253,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently bought and sold shares of CBT. Torren Management LLC acquired a new position in Cabot during the 4th quarter valued at about $26,000. Rothschild Investment LLC grew its position in Cabot by 170.4% in the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the last quarter. Global Retirement Partners LLC increased its stake in shares of Cabot by 1,606.9% in the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares during the period. Geneos Wealth Management Inc. raised its holdings in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 364 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of Cabot during the third quarter valued at approximately $38,000. 93.18% of the stock is currently owned by institutional investors.

Cabot Price Performance

Shares of NYSE:CBT opened at $89.25 on Tuesday. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53. The stock has a market cap of $4.61 billion, a price-to-earnings ratio of 16.87, a PEG ratio of 11.73 and a beta of 0.83. The stock’s 50 day moving average price is $87.09 and its 200 day moving average price is $78.93. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.30 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period last year, the company posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Equities research analysts anticipate that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s payout ratio is presently 35.73%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CBT shares. Truist Financial assumed coverage on Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 price objective for the company. JPMorgan Chase & Co. lifted their target price on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Mizuho boosted their price target on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday, June 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, UBS Group raised their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a report on Friday, May 8th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $85.80.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.